SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 101 filers reported holding SEELOS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $206,000 | -73.8% | 200,135 | -82.7% | 0.00% | -100.0% |
| Q2 2022 | $785,000 | -45.4% | 1,154,419 | -32.8% | 0.00% | -50.0% |
| Q1 2022 | $1,438,000 | +277.4% | 1,716,755 | +984.6% | 0.00% | – |
| Q3 2021 | $381,000 | -67.5% | 158,278 | -64.3% | 0.00% | -100.0% |
| Q2 2021 | $1,171,000 | +5.5% | 443,500 | -36.9% | 0.00% | 0.0% |
| Q4 2020 | $1,110,000 | +100.4% | 702,486 | +18.8% | 0.00% | 0.0% |
| Q3 2020 | $554,000 | -44.0% | 591,086 | -39.7% | 0.00% | 0.0% |
| Q2 2020 | $989,000 | +87.0% | 979,586 | -9.2% | 0.00% | 0.0% |
| Q1 2020 | $529,000 | -64.7% | 1,078,379 | -3.6% | 0.00% | 0.0% |
| Q4 2019 | $1,499,000 | +61.7% | 1,118,623 | +10.8% | 0.00% | 0.0% |
| Q3 2019 | $927,000 | -54.5% | 1,009,958 | +8.7% | 0.00% | -50.0% |
| Q2 2019 | $2,036,000 | +27.1% | 929,465 | +95.0% | 0.00% | +100.0% |
| Q1 2019 | $1,602,000 | – | 476,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENDELL JEFFREY L | 4,933,024 | $4,133,000 | 0.30% |
| ACUTA CAPITAL PARTNERS, LLC | 295,896 | $248,000 | 0.12% |
| Connacht Asset Management LP | 231,551 | $194,000 | 0.10% |
| Uniplan Investment Counsel, Inc. | 1,564,605 | $1,310,000 | 0.08% |
| AdvisorShares Investments LLC | 358,796 | $301,000 | 0.05% |
| 1492 Capital Management LLC | 99,819 | $84,000 | 0.04% |
| Woodline Partners LP | 2,803,230 | $2,349,000 | 0.04% |
| Ikarian Capital, LLC | 257,883 | $215,000 | 0.03% |
| Sovereign Financial Group, Inc. | 75,000 | $63,000 | 0.02% |
| Aquatic Capital Management LLC | 6,400 | $5,000 | 0.01% |